[Concerning the treatment of a late dyskinesia by Tiapridal (author's transl)].
The authors study the effects of Tiapridal on the late dyskinesia resulting from the continuous use of neuroleptics. They present a conclusive observation of the effectiveness of this product on this syndrome. They have come to the conclusion that it is not necessary to prescribe anti-Parkinson drugs, the side-effects of which are well-known, firstly by diminuing the neuroleptic doses as soon as the first symptoms of extra-pyramidal syndrome appear, and secondly, when these symptoms appear by adding some Tiapridal to the dose of neuroleptics already taken.
D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000009:adverse effects; D001549:Benzamides / Q000627:therapeutic use*; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans
D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D001549:Benzamides
A propos du traitement d'une dyskinésie tardive.